242 related articles for article (PubMed ID: 37962623)
21. Natural products: potential treatments for cisplatin-induced nephrotoxicity.
Fang CY; Lou DY; Zhou LQ; Wang JC; Yang B; He QJ; Wang JJ; Weng QJ
Acta Pharmacol Sin; 2021 Dec; 42(12):1951-1969. PubMed ID: 33750909
[TBL] [Abstract][Full Text] [Related]
22. Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury.
Tang J; Shi Y; Liu N; Xu L; Zang X; Li P; Zhang J; Zheng X; Qiu A; Zhuang S
Clin Sci (Lond); 2018 Feb; 132(3):339-359. PubMed ID: 29358506
[TBL] [Abstract][Full Text] [Related]
23. Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin.
Harley G; Katerelos M; Gleich K; de Souza DP; Narayana VK; Kemp BE; Power DA; Mount PF
Biomed Pharmacother; 2022 Sep; 153():113377. PubMed ID: 36076520
[TBL] [Abstract][Full Text] [Related]
24. Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury.
Gong Q; Lai T; Liang L; Jiang Y; Liu F
Mol Med; 2023 Oct; 29(1):140. PubMed ID: 37875838
[TBL] [Abstract][Full Text] [Related]
25. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis.
Hu Z; Zhang H; Yi B; Yang S; Liu J; Hu J; Wang J; Cao K; Zhang W
Cell Death Dis; 2020 Jan; 11(1):73. PubMed ID: 31996668
[TBL] [Abstract][Full Text] [Related]
26. IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer.
Ravichandran K; Holditch S; Brown CN; Wang Q; Ozkok A; Weiser-Evans MC; Nemenoff R; Miyazaki M; Thiessen-Philbrook H; Parikh CR; Ljubanovic D; Edelstein CL
Am J Physiol Renal Physiol; 2018 Mar; 314(3):F356-F366. PubMed ID: 29070568
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of dendropanoxide isolated from Dendropanax morbifera against cisplatin-induced acute kidney injury via the AMPK/mTOR signaling pathway.
Park YJ; Kim KS; Park JH; Lee SH; Kim HR; Lee SH; Choi HB; Cao S; Kumar V; Kwak JH; Kim HS
Food Chem Toxicol; 2020 Nov; 145():111605. PubMed ID: 32750447
[TBL] [Abstract][Full Text] [Related]
28. The water-soluble triptolide derivative PG490-88 protects against cisplatin-induced acute kidney injury.
Kim HJ; Ravichandran K; Ozkok A; Wang Q; He Z; Jani A; Ljubanovic D; Douglas IS; Edelstein CL
J Pharmacol Exp Ther; 2014 Jun; 349(3):518-25. PubMed ID: 24727856
[TBL] [Abstract][Full Text] [Related]
29. The protective role of Achyranthes aspera extract against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and PANoptosis.
Lin SY; Chang CL; Liou KT; Kao YK; Wang YH; Chang CC; Kuo TBJ; Huang HT; Yang CCH; Liaw CC; Shen YC
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117097. PubMed ID: 37648176
[TBL] [Abstract][Full Text] [Related]
30. Loss of sphingosine kinase 2 protects against cisplatin-induced kidney injury.
Xie D; Hu G; Chen C; Ahmadinejad F; Wang W; Li PL; Gewirtz DA; Li N
Am J Physiol Renal Physiol; 2022 Sep; 323(3):F322-F334. PubMed ID: 35834271
[TBL] [Abstract][Full Text] [Related]
31. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.
Wang JN; Liu MM; Wang F; Wei B; Yang Q; Cai YT; Chen X; Liu XQ; Jiang L; Li C; Hu XW; Yu JT; Ma TT; Jin J; Wu YG; Li J; Meng XM
Clin Sci (Lond); 2019 Jul; 133(14):1609-1627. PubMed ID: 31315969
[TBL] [Abstract][Full Text] [Related]
32. Gastrodin alleviates cisplatin nephrotoxicity by inhibiting ferroptosis via the SIRT1/FOXO3A/GPX4 signaling pathway.
Qiu CW; Chen B; Zhu HF; Liang YL; Mao LS
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117282. PubMed ID: 37802374
[TBL] [Abstract][Full Text] [Related]
33. Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation.
Solanki MH; Chatterjee PK; Gupta M; Xue X; Plagov A; Metz MH; Mintz R; Singhal PC; Metz CN
Am J Physiol Renal Physiol; 2014 Aug; 307(4):F369-84. PubMed ID: 24944268
[TBL] [Abstract][Full Text] [Related]
34. Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway.
Yang SK; Han YC; He JR; Yang M; Zhang W; Zhan M; Li AM; Li L; Na-Song ; Liu YT; Wu XQ; Zhang Q; Wang JW; Zhang H
Biomed Pharmacother; 2020 Oct; 130():110521. PubMed ID: 32717631
[TBL] [Abstract][Full Text] [Related]
35. Extracellular vesicles from induced pluripotent stem cell-derived mesenchymal stem cells enhance the recovery of acute kidney injury.
Hong S; Kim H; Kim J; Kim S; Park TS; Kim TM
Cytotherapy; 2024 Jan; 26(1):51-62. PubMed ID: 37843481
[TBL] [Abstract][Full Text] [Related]
36. Yi-Shen-Xie-Zhuo formula alleviates cisplatin-induced AKI by regulating inflammation and apoptosis via the cGAS/STING pathway.
Qi J; Luo Q; Zhang Q; Wu M; Zhang L; Qin L; Xue Q; Nie X
J Ethnopharmacol; 2023 Jun; 309():116327. PubMed ID: 36889420
[TBL] [Abstract][Full Text] [Related]
37. Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.
George B; Joy MS; Aleksunes LM
Exp Biol Med (Maywood); 2018 Feb; 243(3):272-282. PubMed ID: 29231123
[TBL] [Abstract][Full Text] [Related]
38. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
Shinke H; Masuda S; Togashi Y; Ikemi Y; Ozawa A; Sato T; Kim YH; Mishima M; Ichimura T; Bonventre JV; Matsubara K
Cancer Chemother Pharmacol; 2015 Nov; 76(5):989-96. PubMed ID: 26407820
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the cisplatin nephrotoxicity using the urinary neutrophil gelatinase-associated lipocalin (NGAL) in patients with head and neck cancer.
Peres LA; da Cunha AD; Assumpção RA; Schäfer A; da Silva AL; Gaspar AD; Scarpari DF; Alves JB; Girelli Neto R; de Oliveira TF
J Bras Nefrol; 2014; 36(3):280-8. PubMed ID: 25317609
[TBL] [Abstract][Full Text] [Related]
40. The effect of monotropein on alleviating cisplatin-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis.
Zhang Y; Chen Y; Li B; Ding P; Jin D; Hou S; Cai X; Sheng X
Biomed Pharmacother; 2020 Sep; 129():110408. PubMed ID: 32574971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
